Public Health


15 June 2021

Today, the European Commission is presenting a Communication on the early lessons learnt from the COVID-19 pandemic over the past 18 months and building on them to improve action at EU and national level.

08 June 2021

The main purpose of the scientific opinion is to support the Commission by reviewing two reports related to the use of squishy toys published by the Danish Environmental Protection Agency (EPA) and the Swedish Chemical Agency (KEMI).

01 June 2021

Today, the EU Digital COVID Certificate has reached another important milestone with the go-live of the technical system at EU level, which allows to verify certificates in a secure and privacy-friendly way.

26 May 2021

As of today, the Regulation on medical devices (MDR) is fully applicable, after a one year postponement due to the COVID-19 pandemic.

21 May 2021

The report examines the progress achieved so far: the Directive contributed to the reduction of tobacco consumption and generated positive outcomes for public health.

11 May 2021

The Health Security Committee (HSC) has agreed to update the common list of COVID-19 rapid antigen tests (RATs), including those whose results are mutually recognised by EU Member States for public health measures.

10 May 2021

Interested parties are invited to share their views via a questionnaire, until 30 July, to help explore several options in view of the revision of the legislation.

06 May 2021
The Commission is complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID'.
04 May 2021

Stakeholders are invited to share views on how the Directive has improved patients’ rights to healthcare abroad and its role to strengthen European cooperation in the area of rare and complex diseases. This consultation is open for responses until 27 July 2021.

03 May 2021

The purpose of the EHDS is to promote health-data exchange and support research on new preventive strategies, as well as on treatments, medicines, medical devices and outcomes. The consultation will remain open for responses until 26 July 2021.